Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125443661 | 12544366 | 1 | I | 20160616 | 20160711 | 20160711 | PER | US-PFIZER INC-2016306578 | PFIZER | 0.00 | M | Y | 0.00000 | 20160711 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125443661 | 12544366 | 1 | PS | ATORVASTATIN CALCIUM. | ATORVASTATIN CALCIUM | 1 | UNK | U | 20702 | ||||||||||
| 125443661 | 12544366 | 2 | SS | CELECOXIB. | CELECOXIB | 1 | UNK | U | 20998 | ||||||||||
| 125443661 | 12544366 | 3 | SS | LISINOPRIL. | LISINOPRIL | 1 | UNK | U | 0 | ||||||||||
| 125443661 | 12544366 | 4 | SS | EZETIMIBE. | EZETIMIBE | 1 | UNK | U | 0 | ||||||||||
| 125443661 | 12544366 | 5 | SS | PIOGLITAZONE. | PIOGLITAZONE | 1 | UNK | U | 0 | ||||||||||
| 125443661 | 12544366 | 6 | SS | ROSIGLITAZONE | ROSIGLITAZONE | 1 | UNK | U | 0 | ||||||||||
| 125443661 | 12544366 | 7 | SS | LOVASTATIN. | LOVASTATIN | 1 | UNK | U | 0 | ||||||||||
| 125443661 | 12544366 | 8 | SS | NIACIN. | NIACIN | 1 | UNK | U | 0 |
Indications of drugs used
| no results found |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125443661 | 12544366 | Drug hypersensitivity |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |